You are here

  • Home
  • Archive
  • Volume 17, Issue 2
  • A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLE
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20191000
Apr 20192900
May 20192001
Jun 20192200
Jul 20193400
Aug 20192600
Sep 20191400
Oct 20192201
Nov 2019901
Dec 20191400
Jan 20201400
Feb 2020600
Mar 2020400
Apr 2020500
May 20201901
Jun 20201200
Jul 20201400
Aug 20201200
Sep 20201200
Oct 20201000
Nov 2020800
Dec 2020800
Jan 20211400
Feb 2021400
Mar 20211200
Apr 2021200
Oct 20211000
Nov 2021800
Dec 20211400
Jan 20222400
Feb 20221200
Mar 20222202
Apr 20221801
May 20223800
Jun 20223400
Jul 20222400
Aug 20224400
Sep 20223400
Oct 20223500
Nov 20222202
Dec 20221200
Jan 2023600
Feb 20236200
Mar 2023700
Apr 2023601
May 2023802
Jun 20231801
Jul 20231201
Aug 2023600
Sep 20231001
Oct 2023700
Nov 20232402
Dec 20232600
Jan 20242600
Feb 20241600
Mar 20241400
Apr 20241201
Total967018